\-\ Texto\\:\\ \ \(0\)\
\-\ pain\\ with\\ deep\\ palpation\\ of\\ right\\ hip\\ region\\.\ \(0\)\
\-\ no\\ lab\\ tests\\ performed\\.\ \(0\)\
\-\ 1\\.\\ conservative\\ watching\\ and\\ waiting\\.\ \(0\)\
\-\ 2\\.\\ orthopedic\\ treatment\\ options\\:\ \(0\)\
\-\ internal\\ fixation\\ with\\ intramedullary\\ nails\\ \ \(0\)\
\-\ provides\\ stabilization\\ of\\ extensively\\ affected\\ bones\\ \ \(1\)\
\-\ prevents\\ further\\ fractures\\ and\\ major\\ deformities\\ \ \(1\)\
\-\ curettage\\,\\ and\\ bone\\ grafting\\.\ \(1\)\
\-\ 3\\.\\ medical\\ management\\:\\ \ \(0\)\
\-\ intravenous\\ infusions\\ with\\ the\\ bisphosphonate\\ compound\\:\\ i\\.e\\.\\ alendronate\\,\\ pamidronate\\.\ \(0\)\
\-\ these\\ drugs\\ alter\\ bone\\ resorption\\ and\\ may\\ help\\ the\\ pain\\ of\\ fibrous\\ dysplasia\\ \\ and\\ also\\ may\\ strengthen\\ the\\ bone\\.\ \(0\)\
\-\ well\\ circumscribed\\ lytic\\ lesion\ \(1\)\
\-\ large\\ lesion\\:\\ 10\\ cm\\ x\\ 3\\ cm\ \(0\)\
\-\ \\"ground\\ glass\\"\\ ppacity\\ on\\ plain\\ radiographs\ \(0\)\
\-\ fibrous\\ dysplasia\\ of\\ the\\ hip\ \(0\)\
\-\ unicameral\\ bone\\ cyst\ \(4\)\
\-\ eosinophilic\\ granuloma\\ \\(langerhan\\ histiocytosis\\)\ \(0\)\
\-\ fibrous\\ dysplasia\ \(50\)\
\-\ less\\ likely\\ dd\ \(0\)\
\-\ hemangioma\\ of\\ the\\ bone\ \(0\)\
\-\ primary\\ hyperparathyroidism\\ \ \(2\)\
\-\ metastases\\ \\(at\\ this\\ age\\,\\ neuroblastoma\\)\ \(0\)\
\-\ 8\\ y\\.o\\.\\ boy\\ with\\ pain\\ in\\ the\\ right\\ hip\ \(1\)\
\-\ no\\ other\\ pmhx\\ given\ \(0\)\
\-\ this\\ patient\\&\\#39\\;s\\ pain\\ had\\ been\\ increasing\\ and\\ the\\ lesion\\ had\\ grown\\ since\\ the\\ original\\ diagnosis\\.\\ his\\ orthopedic\\ surgeon\\ was\\ opting\\ for\\ curettage\\ due\\ to\\ patients\\ increase\\ in\\ complaints\\.\\ at\\ the\\ time\\ of\\ case\\ submission\\,\\ no\\ definite\\ surgical\\ planning\\ had\\ been\\ performed\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ curettage\\:\\ 0\\.05266347388613879\ \(0\)\
\-\ bone\\:\\ 0\\.05256026439257104\ \(0\)\
\-\ fibrous\\:\\ 0\\.05130038997411494\ \(0\)\
\-\ hip\\:\\ 0\\.05055255998185334\ \(0\)\
\-\ dysplasia\\:\\ 0\\.05009555515016888\ \(0\)\
\-\ ppacity\\:\\ 0\\.043641180316665834\ \(0\)\
\-\ orthopedic\\:\\ 0\\.04038930668883171\ \(0\)\
\-\ alendronate\\:\\ 0\\.04020975863072551\ \(0\)\
\-\ opting\\:\\ 0\\.04020975863072551\ \(0\)\
\-\ pamidronate\\:\\ 0\\.038202505620289054\ \(0\)\
\-\ watching\\:\\ 0\\.03677833694478519\ \(0\)\
\-\ nails\\:\\ 0\\.03677833694478519\ \(0\)\
\-\ infusions\\:\\ 0\\.03567366589867524\ \(0\)\
\-\ bisphosphonate\\:\\ 0\\.03567366589867524\ \(0\)\
\-\ dd\\:\\ 0\\.03567366589867524\ \(0\)\
\-\ extensively\\:\\ 0\\.03334691525884486\ \(0\)\
\-\ alter\\:\\ 0\\.032242244212734916\ \(0\)\
\-\ prevents\\:\\ 0\\.031770411639446175\ \(0\)\
\-\ compound\\:\\ 0\\.0313396622484084\ \(0\)\
\-\ waiting\\:\\ 0\\.03094341122032159\ \(0\)\
\-\ grown\\:\\ 0\\.03094341122032159\ \(0\)\
\-\ strengthen\\:\\ 0\\.030234991202298455\ \(0\)\
\-\ submission\\:\\ 0\\.029915493572904538\ \(0\)\
\-\ langerhan\\:\\ 0\\.02961537168272417\ \(0\)\
\-\ unicameral\\:\\ 0\\.02881082252679459\ \(0\)\
\-\ grafting\\:\\ 0\\.028118931722957173\ \(0\)\
\-\ had\\:\\ 0\\.027383908206545172\ \(0\)\
\-\ stabilization\\:\\ 0\\.02732515622753549\ \(0\)\
\-\ planning\\:\\ 0\\.02732515622753549\ \(0\)\
\-\ resorption\\:\\ 0\\.026971398980099127\ \(0\)\
\-\ intramedullary\\:\\ 0\\.026183949996783844\ \(0\)\
\-\ provides\\:\\ 0\\.026183949996783844\ \(0\)\
\-\ lesion\\:\\ 0\\.025849830089115663\ \(0\)\
\-\ original\\:\\ 0\\.02525716018446629\ \(0\)\
\-\ pmhx\\:\\ 0\\.025021377763727405\ \(0\)\
\-\ glass\\:\\ 0\\.02447681887652776\ \(0\)\
\-\ deformities\\:\\ 0\\.023893734541595168\ \(0\)\
\-\ performed\\:\\ 0\\.023589884467597216\ \(0\)\
\-\ histiocytosis\\:\\ 0\\.02353997729415881\ \(0\)\
\-\ drugs\\:\\ 0\\.02337214783041781\ \(0\)\
\-\ ground\\:\\ 0\\.02329031960293657\ \(0\)\
\-\ been\\:\\ 0\\.023017771182811793\ \(0\)\
\-\ definite\\:\\ 0\\.022900315257129072\ \(0\)\
\-\ cm\\:\\ 0\\.022692634829871147\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.02268025702658039\ \(0\)\
\-\ i\\.e\\:\\ 0\\.022609025653055143\ \(0\)\
\-\ surgeon\\:\\ 0\\.02253880468774843\ \(0\)\
\-\ \\:\\:\\ 0\\.022381679524567624\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.022201906354852315\ \(0\)\
\-\ tests\\:\\ 0\\.022137193079766408\ \(0\)\
\-\ fixation\\:\\ 0\\.021476146581625204\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.021149621988596507\ \(0\)\
\-\ help\\:\\ 0\\.021097235308742364\ \(0\)\
\-\ intravenous\\:\\ 0\\.020994096264668888\ \(0\)\
\-\ granuloma\\:\\ 0\\.02079404904517445\ \(0\)\
\-\ lab\\:\\ 0\\.020696977404637933\ \(0\)\
\-\ pain\\:\\ 0\\.02066550826793534\ \(0\)\
\-\ options\\:\\ 0\\.020554848167596194\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.02039355942556676\ \(0\)\
\-\ major\\:\\ 0\\.019778400288918124\ \(0\)\
\-\ 39\\:\\ 0\\.01966005612627677\ \(0\)\
\-\ lytic\\:\\ 0\\.018936068500929513\ \(0\)\
\-\ hemangioma\\:\\ 0\\.018902505694071203\ \(0\)\
\-\ circumscribed\\:\\ 0\\.01880316132253254\ \(0\)\
\-\ may\\:\\ 0\\.018557706622753703\ \(0\)\
\-\ complaints\\:\\ 0\\.0183642225250788\ \(0\)\
\-\ affected\\:\\ 0\\.01830457728489972\ \(0\)\
\-\ metastases\\:\\ 0\\.018072932921004873\ \(0\)\
\-\ bones\\:\\ 0\\.01785164490655979\ \(0\)\
\-\ increase\\:\\ 0\\.01774460300550451\ \(0\)\
\-\ increasing\\:\\ 0\\.01733818042041936\ \(0\)\
\-\ deep\\:\\ 0\\.01712342648165587\ \(0\)\
\-\ conservative\\:\\ 0\\.016895252683634746\ \(0\)\
\-\ \\#\\:\\ 0\\.016592508014558853\ \(0\)\
\-\ fractures\\:\\ 0\\.01601875543554592\ \(0\)\
\-\ management\\:\\ 0\\.015963026947800205\ \(0\)\
\-\ 8\\:\\ 0\\.015817413654699745\ \(0\)\
\-\ since\\:\\ 0\\.015538438721278301\ \(0\)\
\-\ \\&\\:\\ 0\\.014858355901690256\ \(0\)\
\-\ given\\:\\ 0\\.014502051448100706\ \(0\)\
\-\ 3\\.\\:\\ 0\\.014474624812577858\ \(0\)\
\-\ boy\\:\\ 0\\.01437981079171273\ \(0\)\
\-\ less\\:\\ 0\\.014326435664963775\ \(0\)\
\-\ 10\\:\\ 0\\.014260515981915398\ \(0\)\
\-\ internal\\:\\ 0\\.014182553818706789\ \(0\)\
\-\ palpation\\:\\ 0\\.014118510298752733\ \(0\)\
\-\ x\\:\\ 0\\.013955773937363749\ \(0\)\
\-\ plain\\:\\ 0\\.013738929270738042\ \(0\)\
\-\ 2\\.\\:\\ 0\\.013452693771288406\ \(0\)\
\-\ further\\:\\ 0\\.013452693771288406\ \(0\)\
\-\ radiographs\\:\\ 0\\.013397380401990757\ \(0\)\
\-\ 1\\.\\:\\ 0\\.01321380775394852\ \(0\)\
\-\ medical\\:\\ 0\\.013016385148841606\ \(0\)\
\-\ age\\:\\ 0\\.012875793690813398\ \(0\)\
\-\ no\\:\\ 0\\.01277887352530399\ \(0\)\
\-\ primary\\:\\ 0\\.012531605261859884\ \(0\)\
\-\ y\\.o\\:\\ 0\\.012209799171221287\ \(0\)\
\-\ his\\:\\ 0\\.012192519938846198\ \(0\)\
\-\ s\\:\\ 0\\.01213251320353756\ \(0\)\
\-\ region\\:\\ 0\\.01194852092692729\ \(0\)\
\-\ time\\:\\ 0\\.01194852092692729\ \(0\)\
\-\ likely\\:\\ 0\\.011932128544235924\ \(0\)\
\-\ at\\:\\ 0\\.011463001513184485\ \(0\)\
\-\ cyst\\:\\ 0\\.01136817394072328\ \(0\)\
\-\ due\\:\\ 0\\.011288500757192276\ \(0\)\
\-\ these\\:\\ 0\\.01100913213840515\ \(0\)\
\-\ patients\\:\\ 0\\.010948389105772406\ \(0\)\
\-\ \\;\\:\\ 0\\.010026837566596999\ \(0\)\
\-\ 3\\:\\ 0\\.009905819439141286\ \(0\)\
\-\ other\\:\\ 0\\.009750685884665588\ \(0\)\
\-\ diagnosis\\:\\ 0\\.009713957083071385\ \(0\)\
\-\ well\\:\\ 0\\.009569707687963619\ \(0\)\
\-\ this\\:\\ 0\\.009516210032813199\ \(0\)\
\-\ case\\:\\ 0\\.009254972439936985\ \(0\)\
\-\ large\\:\\ 0\\.009250210058569701\ \(0\)\
\-\ right\\:\\ 0\\.008927046624855611\ \(0\)\
\-\ surgical\\:\\ 0\\.00889218698144284\ \(0\)\
\-\ treatment\\:\\ 0\\.008562460196043994\ \(0\)\
\-\ also\\:\\ 0\\.008339700958763126\ \(0\)\
\-\ \\(\\:\\ 0\\.007152096299444164\ \(0\)\
\-\ \\)\\:\\ 0\\.007064729624884209\ \(0\)\
\-\ the\\:\\ 0\\.0061596215957061\ \(0\)\
\-\ \\,\\:\\ 0\\.005360595356777968\ \(0\)\
\-\ and\\:\\ 0\\.005346802150461934\ \(0\)\
\-\ was\\:\\ 0\\.004892462981255875\ \(0\)\
\-\ patient\\:\\ 0\\.0042405541134474655\ \(0\)\
\-\ in\\:\\ 0\\.00417224980336886\ \(0\)\
\-\ for\\:\\ 0\\.003609446280409481\ \(0\)\
\-\ on\\:\\ 0\\.0035836188730961785\ \(0\)\
\-\ of\\:\\ 0\\.0034605089345937155\ \(0\)\
\-\ with\\:\\ 0\\.0023169143780176187\ \(0\)\
\-\ to\\:\\ 0\\.002114198556648447\ \(0\)\
\-\ \\.\\:\\ 0\\.0019331430548059853\ \(0\)\
